Using Creyos Cognitive Assessments to Identify ADHD and Its Subtypes
By Dr. Douglas Cowan, Psy.D., Marriage and Family Therapist
ADHD isn’t a one-size-fits-all condition. It impacts individuals differently—some struggle to sit still, others drift off into daydreams, and some freeze when things don’t go as planned.
Creyos Cognitive Assessments provide a fast, objective way to evaluate attention, impulse control, working memory, and reasoning. When interpreted alongside behavioral observations and self-reports, Creyos results can reveal distinct ADHD subtypes—and guide targeted interventions.
🧪 What is the Creyos Cognitive Assessment?
Creyos evaluates 12 core brain functions through gamified cognitive tasks, grouped into:
- Attention and response inhibition
- Working and short-term memory
- Reasoning and planning
- Speed and flexibility
It gives percentile scores in each domain, allowing clinicians to compare an individual’s performance to age-matched norms.
⏱️ Why Timed Tasks Are Key in ADHD
ADHD often reveals itself under pressure.
Creyos includes several timed tasks that expose executive function issues, including:
- Double Trouble – Tests response inhibition and focus
- Feature Match – Measures sustained attention
- Mental Rotation – Challenges visual processing speed
- Reaction Time – Evaluates alertness and processing speed
Red flags for ADHD include:
- Lower scores on timed tasks vs. untimed tasks
- Poor performance on Double Trouble
- Inconsistent reaction times
- Above-average reasoning but weak attention or inhibition
📉 Subtests Most Commonly Affected in ADHD
- Double Trouble (Inhibition) – Often the lowest score in ADHD profiles
- Feature Match (Sustained Attention) – Can show distractibility or impulsivity
- Token Search (Working Memory) – Difficulty tracking spatial info over time
- Digit Span (Verbal STM) – Trouble holding auditory info in mind
🧠 ADHD Subtype Patterns on Creyos
Different ADHD subtypes can present differently on cognitive tasks:
🔹 Inattentive Type (Pooh)
- Low: Feature Match, Token Search, Digit Span
- May work slowly or lose track of goals
- Timed tasks show delay or errors from distraction
🔸 Hyperactive/Impulsive Type (Tigger)
- Low: Double Trouble, Reaction Time
- Fast but error-prone, impulsive choices
- Highly inconsistent scores
🔹 Over-Focused Type (Rabbit)
- Low: Double Trouble, Spatial Planning
- May get stuck on certain parts of tasks
- Rigid or perfectionistic patterns
🔸 Anxious Type (Piglet)
- Slightly slow on timed tasks
- Hesitant and careful—may avoid errors but take too long
- Average reasoning, but slower planning
🔹 Depressive Type (Eeyore)
- Mildly depressed scores across memory and processing
- Slow cognitive initiation
- Poor planning and low motivation
🧾 Use with Self-Report Inventories
Pair Creyos with:
- ASRS v1.1 (Adult ADHD Self-Report)
- GAD-7 or PHQ-9 for anxiety/depression screening
When low inhibition scores (Double Trouble) align with ASRS indicators, ADHD is strongly indicated.
🧩 Clinical Takeaways
- Compare timed vs. untimed scores—gaps can reveal executive dysfunction
- Low Double Trouble + high ASRS = ADHD likelihood
- Inconsistent task performance = red flag for impulsivity or distractibility
- Overly cautious, slow results = possible anxiety overlay
🧠 What to Do Next
For clients with ADHD-like Creyos profiles:
✅ Recommend:
- CES CalmBox – Enhances focus, reduces stress reactivity
- Dual-N-Back training – Improves memory and attention control
- LifeWave Patches
- X39 for cellular repair and energy
- Aeon to reduce inflammation and emotional reactivity
- Carnosine for brain stamina and protection
🧠 Final Thoughts
Creyos doesn’t diagnose ADHD on its own—but it shines a spotlight on where cognitive functions are breaking down.
When paired with good clinical interviews and behavioral checklists, it becomes a powerful tool for guiding targeted, brain-based interventions.
We use Creyos Assessments as a part of our CalmWaves Brain Health and Performance Programs.
📝 Disclaimer: This article is for educational purposes only and should not be used to diagnose ADHD without a full clinical evaluation.